We have studied the significance of both a specific SNP of CRP and mutations in KRAS/BRAF in liver metastases with respect to the CRC-specific survival (CSS) of patients after colorectal liver metastasectomy. The gene discussed is KRAS; the disease is colorectal carcinoma.